Defining the critical hurdles in cancer immunotherapy.
Journal of Translational Medicine.
Times cited: 107
Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 292